Literature DB >> 33846449

Structural basis for an exceptionally strong preference for asparagine residue at the S2 subsite of Stenotrophomonas maltophilia dipeptidyl peptidase 7.

Akihiro Nakamura1, Yoshiyuki Suzuki2, Yasumitsu Sakamoto3, Saori Roppongi4, Chisato Kushibiki3, Natsuri Yonezawa3,5, Masato Takahashi3, Yosuke Shida6, Hiroaki Gouda5, Takamasa Nonaka3, Nobutada Tanaka7,8, Wataru Ogasawara9,10.   

Abstract

The emergence of drug-resistant bacteria has become a major problem worldwide. Bacterial dipeptidyl peptidases 7 and 11 (DPP7s and DPP11s), belonging to the family-S46 peptidases, are important enzymes for bacterial growth and are not present in mammals. Therefore, specific inhibitors for these peptidases are promising as potential antibiotics. While the molecular mechanisms underlining strict specificity at the S1 subsite of S46 peptidases have been well studied, those of relatively broad preference at the S2 subsite of these peptidases are unknown. In this study, we performed structural and biochemical analyses on DPP7 from Stenotrophomonas maltophilia (SmDPP7). SmDPP7 showed preference for the accommodation of hydrophobic amino acids at the S2 subsite in general, but as an exception, also for asparagine, a hydrophilic amino acid. Structural analyses of SmDPP7 revealed that this exceptional preference to asparagine is caused by a hydrogen bonding network at the bottom of the S2 subsite. The residues in the S2 subsite are well conserved among S46 peptidases as compared with those in the S1 subsite. We expect that our findings will contribute toward the development of a universal inhibitor of S46 peptidases.

Entities:  

Year:  2021        PMID: 33846449     DOI: 10.1038/s41598-021-86965-x

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  31 in total

Review 1.  Therapies for multidrug resistant and extensively drug-resistant non-fermenting gram-negative bacteria causing nosocomial infections: a perilous journey toward 'molecularly targeted' therapy.

Authors:  Nadim G El Chakhtoura; Elie Saade; Alina Iovleva; Mohamad Yasmin; Brigid Wilson; Federico Perez; Robert A Bonomo
Journal:  Expert Rev Anti Infect Ther       Date:  2018-01-16       Impact factor: 5.091

2.  Identification of a new subtype of dipeptidyl peptidase 11 and a third group of the S46-family members specifically present in the genus Bacteroides.

Authors:  Takayuki K Nemoto; Gustavo Arruda Bezerra; Toshio Ono; Haruka Nishimata; Taku Fujiwara; Yuko Ohara-Nemoto
Journal:  Biochimie       Date:  2018-01-11       Impact factor: 4.079

Review 3.  Stenotrophomonas maltophilia: an emerging global opportunistic pathogen.

Authors:  Joanna S Brooke
Journal:  Clin Microbiol Rev       Date:  2012-01       Impact factor: 26.132

4.  Clinical features of Stenotrophomonas maltophilia pneumonia in immunocompromised patients.

Authors:  J Fujita; I Yamadori; G Xu; S Hojo; K Negayama; H Miyawaki; Y Yamaji; J Takahara
Journal:  Respir Med       Date:  1996-01       Impact factor: 3.415

Review 5.  Attributable mortality of Stenotrophomonas maltophilia infections: a systematic review of the literature.

Authors:  Matthew E Falagas; Antonia C Kastoris; Evridiki K Vouloumanou; Petros I Rafailidis; Anastasios M Kapaskelis; George Dimopoulos
Journal:  Future Microbiol       Date:  2009-11       Impact factor: 3.165

6.  New strategies against Stenotrophomonas maltophilia: a serious worldwide intrinsically drug-resistant opportunistic pathogen.

Authors:  Joanna S Brooke
Journal:  Expert Rev Anti Infect Ther       Date:  2013-12-04       Impact factor: 5.091

Review 7.  The emergence of epidemic, multiple-antibiotic-resistant Stenotrophomonas (Xanthomonas) maltophilia and Burkholderia (Pseudomonas) cepacia.

Authors:  R C Spencer
Journal:  J Hosp Infect       Date:  1995-06       Impact factor: 3.926

Review 8.  Drug repurposing for antimicrobial discovery.

Authors:  Maya A Farha; Eric D Brown
Journal:  Nat Microbiol       Date:  2019-03-04       Impact factor: 17.745

Review 9.  Update on infections caused by Stenotrophomonas maltophilia with particular attention to resistance mechanisms and therapeutic options.

Authors:  Ya-Ting Chang; Chun-Yu Lin; Yen-Hsu Chen; Po-Ren Hsueh
Journal:  Front Microbiol       Date:  2015-09-02       Impact factor: 5.640

Review 10.  Infections Caused by Stenotrophomonas maltophilia in Recipients of Hematopoietic Stem Cell Transplantation.

Authors:  Khalid Ahmed Al-Anazi; Asma M Al-Jasser
Journal:  Front Oncol       Date:  2014-08-25       Impact factor: 6.244

View more
  1 in total

1.  7-Aminocoumarin-4-acetic Acid as a Fluorescent Probe for Detecting Bacterial Dipeptidyl Peptidase Activities in Water-in-Oil Droplets and in Bulk.

Authors:  Akihiro Nakamura; Nobuyuki Honma; Yuma Tanaka; Yoshiyuki Suzuki; Yosuke Shida; Yuko Tsuda; Koushi Hidaka; Wataru Ogasawara
Journal:  Anal Chem       Date:  2021-12-28       Impact factor: 6.986

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.